Longitudinal Study of Brain Amyloid imaGing in MEMENTO

NCT02164643 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

448

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease (AD) and Related Disorders

Interventions

DRUG: Flutemetamol (18F)
DRUG: Florbetapir (18F)

Sponsor

University Hospital, Bordeaux

Collaborators

[object Object]
[object Object]
[object Object]